๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
RBC Bioscience Corporation (TPEX:6848)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
18.60
-1.45 (-7.23%)
Nov 20, 2026, 1:48 PM CST

RBC Bioscience Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
209.59219.71205.25172.47173.89251.18
Revenue Growth
-4.80%7.05%19.00%-0.82%-30.77%-56.33%
Gross Profit
99.34101.4698.0772.973.01117.07
Operating Income
20.6635.0335.3814.547.7548.61
Net Income
15.3123.5421.576.433.7828.73
Earnings Per Share
1.071.641.500.450.262.13
EPS Growth
-31.38%9.33%236.70%69.01%-87.61%-80.17%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Europe
146.34140.56112.03105.15148.2
Asia
31.6923.9318.0719.6641.86
Africa
14.5113.9916.5610.2717.89
Taiwan
14.3113.8314.6720.0117.32
America
12.8412.8311.0818.7925.9
Other Countries
0.020.110.07--
Total
219.71205.25172.47173.89251.18

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
21.6736.4479.8665.1875.9397.47
Total Debt
395.23391.17454.7471.65481.75510.99
Net Cash (Debt)
-373.57-354.73-374.84-406.47-405.82-413.52
Net Cash Growth
------
Net Cash Per Share
-26.00-24.66-26.11-28.42-28.35-30.57

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
43.4340.5255.9313.216.6-25.3
Capital Expenditures
-1.04-6.44-2.13-4.99-9.96-449.72
Free Cash Flow
42.434.0853.88.21-3.36-475.02
Free Cash Flow Growth
11.53%-36.64%554.94%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
47.40%46.18%47.78%42.27%41.98%46.61%
Operating Margin
9.86%15.94%17.24%8.43%4.46%19.35%
Pretax Margin
9.19%13.56%13.14%4.56%2.83%14.31%
Profit Margin
7.31%10.72%10.51%3.73%2.17%11.44%
FCF Margin
20.23%15.51%26.21%4.76%-1.93%-189.12%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
3.5351.5000.5600.4001.0180.827
Dividend Per Share Growth
1478.20%167.86%40.00%-60.71%23.19%-82.05%
Dividend Yield
19.00%8.90%3.23%2.72%7.07%2.57%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.4310.2211.4932.6954.4415.99
P/FCF Ratio
6.267.064.6125.59--
PS Ratio
1.271.101.211.221.181.83